Skip to content

PROPPER Prospective Registry of Outcomes With Penile Prosthesis

Prospective Registry of Outcomes With Penile Prosthesis for Erectile Restoration (PROPPER)

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01383018
Acronym
PROPPER
Enrollment
1457
Registered
2011-06-28
Start date
2011-06-13
Completion date
2018-07-25
Last updated
2021-02-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Erectile Dysfunction, Impotence

Keywords

Erectile Dysfunction (ED), Penile Implant, Impotence, Penile Prosthesis, Registry

Brief summary

The purpose of this observational registry is to collect and better understand real-world outcomes for men undergoing penile implant surgery to treat erectile dysfunction.

Detailed description

A prospective, multi-center, observational registry to be conducted at multiple sites throughout the United States and Canada, to collect real-world penile prosthetic outcomes according to investigators' standard of care. Using questionnaires as well as electronic data collection, investigating physicians will prospectively measure patient responses at regular intervals over a one- to five year period. The physician researchers have identified key metrics for the study including effectiveness, durability, complications, and patient satisfaction; quality of life will also be analyzed, being defined through several validated patient surveys.

Interventions

DEVICEAMS Penile Prosthesis Devices

Non-interventional device registry. Outcomes for patients receiving marketed AMS penile prosthesis devices.

Sponsors

Boston Scientific Corporation
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
MALE
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

Men diagnosed with erectile dysfunction (ED) for whom an AMS penile prosthesis is recommended by their physician are eligible for inclusion. Potentially eligible men should also meet the following inclusion criteria for study enrollment: * Willing and able to provide written informed consent prior to enrollment (if applicable). * Willing to be seen or contacted by phone by the investigator and answer at least 2 questions related to satisfaction and device use 1 year following implantation of an AMS penile prosthesis.

Exclusion criteria

\- Men who are deemed by their physician to be not suitable for a penile implant will be excluded.

Design outcomes

Primary

MeasureTime frameDescription
Number of Participants With Penile Prosthesis That Are Using the Device Less Than Desired or Dissatisfied - Reason Device Used Less Than Desired or Dissatisfied1 year, post implantationReason why subject is using penile prosthesis less than desired or dissatisfied (effectiveness objective 1) measured using a non-validated, standard question, evaluated overall and by penile prosthesis.
Number of Participants With Penile Prosthesis That Are Using the Device Indicating How Often Their Use is.1 year, post implantationPenile prosthesis use at year (effectiveness objective 1) measured using a non-validated, standard question, evaluated overall and by penile prosthesis.
Number of Times Per Month Participants With Penile Prosthesis Are Using the Device.1 year, post implantationPenile prosthesis use at 1 year measured in number of times per month (effectiveness objective 1) measured using a non-validated, standard question, evaluated overall and by penile prosthesis.
Number of Participants With Penile Prosthesis That Were Not Using the Device, Reasons for Non-use1 year, post implantationPenile prosthesis reasons for non-use at 1 year (effectiveness objective 1) measured using a non-validated, standard question, evaluated overall and by penile prosthesis.
Number of Participants With Penile Prosthesis Using the Device But Not as Often as Desired1 year, post implantationNumber of penile prosthesis subjects using the device but indicated that they were not using as often as desired (effectiveness objective 1) measured using a non-validated, standard question, evaluated overall and by penile prosthesis.
Number of Participants With Penile Prosthesis Overall Subject Satisfaction1 year, post-implantationPenile prosthesis overall subject satisfaction (effectiveness objective 1) measured using a non-validated, standard question, evaluated overall and by penile prosthesis.
Number of Participants With Penile Prosthesis That Are Using the Device1 year, post implantationNumber of subjects using penile prosthesis at 1 year (effectiveness objective 1) measured using a non-validated, standard question, evaluated overall and by penile prosthesis.

Other

MeasureTime frameDescription
Erection Hardness Scale Over Five YearsBaseline through 5 yearsThe Erection Hardness Scale (EHS), an easy-to-use, four-point scale for erectile dysfunction, provides a reliable measure of erection hardness and an indicator of other health and wellbeing outcomes, according to new data reported at the European Association of Urology. EHS rates the hardness of erection on a scale of zero to four, with four being the maximal score. A higher score indicates a harder penis while a lower score indicates greater dysfunction.
American Urology Association - Symptom Index Over Five YearsBaseline through 5 yearsThe AUA-SI contains seven symptoms questions which include feeling of incomplete bladder emptying, frequency, intermittency, urgency, weak stream, straining and nocturia, each referring to during the last month, and each involving assignment of a score from 0 to 5 for a total score of maximum 35 points from non-missing items. The lower score means a better quality of life.
UCLA Prostate Cancer Index Over Five YearsBaseline through 5 yearsThe University of California Los Angeles-Prostate Cancer Index -UCLA-PCI is a validated, twenty question questionnaire to asses impact of treatment for early stage prostate cancer on quality of life. The UCLA-PCI is analyzed in six sections, Sexual Function and Sexual Bother, Urinary Function and Urinary Bother, and Bowel Function and Bowel Bother. This is to measure not just the impact on function but also the quality of life impact. The UCLA PCI domain is scored on a scale of 0-100 points with higher values representing better outcomes.
Subject Reported 5-question International Index of Erectile Function (IIEF-5) Total Score, Baseline Through Five YearsBaseline through 5 yearsPenile prosthesis International Index of Erectile Function (IIEF-5) score (effectiveness objective 2) measured using a validated, multi-dimensional, self-administered questionnaire. Overall responses are reported. A higher score demonstrates an improvement in erectile function while a lower score indicates a loss of erectile function. The 5-question International Index of Erectile Function (IIEF-5) Questionnaire is a validated, multi-dimensional, self-administered investigation that has been found useful in the clinical assessment of erectile dysfunction and treatment outcomes in clinical trials. A score of 0 to 5 is awarded to each of the 5 questions that examine the 4 main domains of male sexual function: erectile function, orgasmic function, sexual desire, and intercourse satisfaction. The subscales are summed to calculated the total score. The minimum total score for this questionnaire is 0 with a maximum of 30.

Countries

Canada, United States

Participant flow

Participants by arm

ArmCount
AMS Penile Prosthesis Recipients
Men for whom an AMS penile prosthesis is recommended AMS Penile Prosthesis Devices: Non-interventional device registry. Outcomes for patients receiving marketed AMS penile prosthesis devices.
1,380
Total1,380

Withdrawals & dropouts

PeriodReasonFG000
Overall StudyAdverse Event14
Overall StudyDeath10
Overall StudyLost to Follow-up5
Overall StudyMissed Visit247
Overall StudyPatient moved away from site1
Overall StudyPhysician Decision5
Overall StudySite closed early-not compliance related7
Overall StudySubject Incarcerated1
Overall StudySubject not implanted76
Overall StudyWithdrawal by Subject9

Baseline characteristics

CharacteristicAMS Penile Prosthesis Recipients
Age, Continuous63.8 years
STANDARD_DEVIATION 9.7
Ethnicity (NIH/OMB)
Hispanic or Latino
77 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
1303 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants
Primary ED etiology
Cardiovascular disease
251 Participants
Primary ED etiology
Diabetes
283 Participants
Primary ED etiology
Other
335 Participants
Primary ED etiology
Peyronies disease
123 Participants
Primary ED etiology
Priaprism
19 Participants
Primary ED etiology
Radical prostatectomy (RP)
369 Participants
Race (NIH/OMB)
American Indian or Alaska Native
3 Participants
Race (NIH/OMB)
Asian
15 Participants
Race (NIH/OMB)
Black or African American
187 Participants
Race (NIH/OMB)
More than one race
0 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
3 Participants
Race (NIH/OMB)
Unknown or Not Reported
20 Participants
Race (NIH/OMB)
White
1152 Participants
Sex: Female, Male
Female
0 Participants
Sex: Female, Male
Male
1380 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
44 / 1,380
other
Total, other adverse events
72 / 1,380
serious
Total, serious adverse events
36 / 1,380

Outcome results

Primary

Number of Participants With Penile Prosthesis Overall Subject Satisfaction

Penile prosthesis overall subject satisfaction (effectiveness objective 1) measured using a non-validated, standard question, evaluated overall and by penile prosthesis.

Time frame: 1 year, post-implantation

Population: Subjects who received an AMS penile prosthesis and completed 1 year follow-up visit.

ArmMeasureCategoryValue (COUNT_OF_PARTICIPANTS)
All AMS Penile Prosthesis Recipients - Total ReponsesNumber of Participants With Penile Prosthesis Overall Subject SatisfactionSatisfied297 Participants
All AMS Penile Prosthesis Recipients - Total ReponsesNumber of Participants With Penile Prosthesis Overall Subject SatisfactionDissatisfied37 Participants
All AMS Penile Prosthesis Recipients - Total ReponsesNumber of Participants With Penile Prosthesis Overall Subject SatisfactionVery Satisfied643 Participants
All AMS Penile Prosthesis Recipients - Total ReponsesNumber of Participants With Penile Prosthesis Overall Subject SatisfactionNeither Satisfied nor Dissatisfied71 Participants
All AMS Penile Prosthesis Recipients - Total ReponsesNumber of Participants With Penile Prosthesis Overall Subject SatisfactionVery Dissatisfied34 Participants
AMS 700Number of Participants With Penile Prosthesis Overall Subject SatisfactionNeither Satisfied nor Dissatisfied68 Participants
AMS 700Number of Participants With Penile Prosthesis Overall Subject SatisfactionSatisfied286 Participants
AMS 700Number of Participants With Penile Prosthesis Overall Subject SatisfactionVery Satisfied627 Participants
AMS 700Number of Participants With Penile Prosthesis Overall Subject SatisfactionDissatisfied35 Participants
AMS 700Number of Participants With Penile Prosthesis Overall Subject SatisfactionVery Dissatisfied34 Participants
AMS AmbicorNumber of Participants With Penile Prosthesis Overall Subject SatisfactionNeither Satisfied nor Dissatisfied2 Participants
AMS AmbicorNumber of Participants With Penile Prosthesis Overall Subject SatisfactionVery Dissatisfied0 Participants
AMS AmbicorNumber of Participants With Penile Prosthesis Overall Subject SatisfactionDissatisfied2 Participants
AMS AmbicorNumber of Participants With Penile Prosthesis Overall Subject SatisfactionSatisfied5 Participants
AMS AmbicorNumber of Participants With Penile Prosthesis Overall Subject SatisfactionVery Satisfied12 Participants
SpectraNumber of Participants With Penile Prosthesis Overall Subject SatisfactionSatisfied6 Participants
SpectraNumber of Participants With Penile Prosthesis Overall Subject SatisfactionDissatisfied0 Participants
SpectraNumber of Participants With Penile Prosthesis Overall Subject SatisfactionVery Dissatisfied0 Participants
SpectraNumber of Participants With Penile Prosthesis Overall Subject SatisfactionNeither Satisfied nor Dissatisfied1 Participants
SpectraNumber of Participants With Penile Prosthesis Overall Subject SatisfactionVery Satisfied4 Participants
Primary

Number of Participants With Penile Prosthesis That Are Using the Device

Number of subjects using penile prosthesis at 1 year (effectiveness objective 1) measured using a non-validated, standard question, evaluated overall and by penile prosthesis.

Time frame: 1 year, post implantation

Population: Subjects who received an AMS penile prosthesis and completed 1 year follow-up visit.

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
All AMS Penile Prosthesis Recipients - Total ReponsesNumber of Participants With Penile Prosthesis That Are Using the Device984 Participants
AMS 700Number of Participants With Penile Prosthesis That Are Using the Device956 Participants
AMS AmbicorNumber of Participants With Penile Prosthesis That Are Using the Device18 Participants
SpectraNumber of Participants With Penile Prosthesis That Are Using the Device10 Participants
Primary

Number of Participants With Penile Prosthesis That Are Using the Device Indicating How Often Their Use is.

Penile prosthesis use at year (effectiveness objective 1) measured using a non-validated, standard question, evaluated overall and by penile prosthesis.

Time frame: 1 year, post implantation

Population: Subjects who received an AMS penile prosthesis and completed 1 year follow-up visit who answered that they were using the device and responded to how often they were using it.

ArmMeasureCategoryValue (COUNT_OF_PARTICIPANTS)
All AMS Penile Prosthesis Recipients - Total ReponsesNumber of Participants With Penile Prosthesis That Are Using the Device Indicating How Often Their Use is.Less than once per month58 Participants
All AMS Penile Prosthesis Recipients - Total ReponsesNumber of Participants With Penile Prosthesis That Are Using the Device Indicating How Often Their Use is.More than once per month837 Participants
AMS 700Number of Participants With Penile Prosthesis That Are Using the Device Indicating How Often Their Use is.More than once per month811 Participants
AMS 700Number of Participants With Penile Prosthesis That Are Using the Device Indicating How Often Their Use is.Less than once per month56 Participants
AMS AmbicorNumber of Participants With Penile Prosthesis That Are Using the Device Indicating How Often Their Use is.Less than once per month1 Participants
AMS AmbicorNumber of Participants With Penile Prosthesis That Are Using the Device Indicating How Often Their Use is.More than once per month17 Participants
SpectraNumber of Participants With Penile Prosthesis That Are Using the Device Indicating How Often Their Use is.Less than once per month1 Participants
SpectraNumber of Participants With Penile Prosthesis That Are Using the Device Indicating How Often Their Use is.More than once per month9 Participants
Primary

Number of Participants With Penile Prosthesis That Are Using the Device Less Than Desired or Dissatisfied - Reason Device Used Less Than Desired or Dissatisfied

Reason why subject is using penile prosthesis less than desired or dissatisfied (effectiveness objective 1) measured using a non-validated, standard question, evaluated overall and by penile prosthesis.

Time frame: 1 year, post implantation

Population: Subjects who received an AMS penile prosthesis and completed 1 year follow-up visit and responded that they were using the device less than desired or dissatisfied.

ArmMeasureCategoryValue (COUNT_OF_PARTICIPANTS)
All AMS Penile Prosthesis Recipients - Total ReponsesNumber of Participants With Penile Prosthesis That Are Using the Device Less Than Desired or Dissatisfied - Reason Device Used Less Than Desired or DissatisfiedDevice problem6 Participants
All AMS Penile Prosthesis Recipients - Total ReponsesNumber of Participants With Penile Prosthesis That Are Using the Device Less Than Desired or Dissatisfied - Reason Device Used Less Than Desired or DissatisfiedLoss of partner4 Participants
All AMS Penile Prosthesis Recipients - Total ReponsesNumber of Participants With Penile Prosthesis That Are Using the Device Less Than Desired or Dissatisfied - Reason Device Used Less Than Desired or DissatisfiedOther reason87 Participants
All AMS Penile Prosthesis Recipients - Total ReponsesNumber of Participants With Penile Prosthesis That Are Using the Device Less Than Desired or Dissatisfied - Reason Device Used Less Than Desired or DissatisfiedPartner disinterest9 Participants
All AMS Penile Prosthesis Recipients - Total ReponsesNumber of Participants With Penile Prosthesis That Are Using the Device Less Than Desired or Dissatisfied - Reason Device Used Less Than Desired or DissatisfiedDevice dissatisfaction14 Participants
All AMS Penile Prosthesis Recipients - Total ReponsesNumber of Participants With Penile Prosthesis That Are Using the Device Less Than Desired or Dissatisfied - Reason Device Used Less Than Desired or DissatisfiedHealth decline13 Participants
AMS 700Number of Participants With Penile Prosthesis That Are Using the Device Less Than Desired or Dissatisfied - Reason Device Used Less Than Desired or DissatisfiedPartner disinterest8 Participants
AMS 700Number of Participants With Penile Prosthesis That Are Using the Device Less Than Desired or Dissatisfied - Reason Device Used Less Than Desired or DissatisfiedLoss of partner4 Participants
AMS 700Number of Participants With Penile Prosthesis That Are Using the Device Less Than Desired or Dissatisfied - Reason Device Used Less Than Desired or DissatisfiedDevice dissatisfaction14 Participants
AMS 700Number of Participants With Penile Prosthesis That Are Using the Device Less Than Desired or Dissatisfied - Reason Device Used Less Than Desired or DissatisfiedHealth decline12 Participants
AMS 700Number of Participants With Penile Prosthesis That Are Using the Device Less Than Desired or Dissatisfied - Reason Device Used Less Than Desired or DissatisfiedDevice problem5 Participants
AMS 700Number of Participants With Penile Prosthesis That Are Using the Device Less Than Desired or Dissatisfied - Reason Device Used Less Than Desired or DissatisfiedOther reason74 Participants
AMS AmbicorNumber of Participants With Penile Prosthesis That Are Using the Device Less Than Desired or Dissatisfied - Reason Device Used Less Than Desired or DissatisfiedPartner disinterest0 Participants
AMS AmbicorNumber of Participants With Penile Prosthesis That Are Using the Device Less Than Desired or Dissatisfied - Reason Device Used Less Than Desired or DissatisfiedHealth decline1 Participants
AMS AmbicorNumber of Participants With Penile Prosthesis That Are Using the Device Less Than Desired or Dissatisfied - Reason Device Used Less Than Desired or DissatisfiedDevice dissatisfaction0 Participants
AMS AmbicorNumber of Participants With Penile Prosthesis That Are Using the Device Less Than Desired or Dissatisfied - Reason Device Used Less Than Desired or DissatisfiedOther reason9 Participants
AMS AmbicorNumber of Participants With Penile Prosthesis That Are Using the Device Less Than Desired or Dissatisfied - Reason Device Used Less Than Desired or DissatisfiedDevice problem1 Participants
AMS AmbicorNumber of Participants With Penile Prosthesis That Are Using the Device Less Than Desired or Dissatisfied - Reason Device Used Less Than Desired or DissatisfiedLoss of partner0 Participants
SpectraNumber of Participants With Penile Prosthesis That Are Using the Device Less Than Desired or Dissatisfied - Reason Device Used Less Than Desired or DissatisfiedDevice problem0 Participants
SpectraNumber of Participants With Penile Prosthesis That Are Using the Device Less Than Desired or Dissatisfied - Reason Device Used Less Than Desired or DissatisfiedPartner disinterest1 Participants
SpectraNumber of Participants With Penile Prosthesis That Are Using the Device Less Than Desired or Dissatisfied - Reason Device Used Less Than Desired or DissatisfiedHealth decline0 Participants
SpectraNumber of Participants With Penile Prosthesis That Are Using the Device Less Than Desired or Dissatisfied - Reason Device Used Less Than Desired or DissatisfiedDevice dissatisfaction0 Participants
SpectraNumber of Participants With Penile Prosthesis That Are Using the Device Less Than Desired or Dissatisfied - Reason Device Used Less Than Desired or DissatisfiedOther reason4 Participants
SpectraNumber of Participants With Penile Prosthesis That Are Using the Device Less Than Desired or Dissatisfied - Reason Device Used Less Than Desired or DissatisfiedLoss of partner0 Participants
Primary

Number of Participants With Penile Prosthesis That Were Not Using the Device, Reasons for Non-use

Penile prosthesis reasons for non-use at 1 year (effectiveness objective 1) measured using a non-validated, standard question, evaluated overall and by penile prosthesis.

Time frame: 1 year, post implantation

Population: Subjects who received an AMS penile prosthesis and completed 1 year follow-up visit who had answered that they were not using the device and responded to the reason for non-use.

ArmMeasureCategoryValue (COUNT_OF_PARTICIPANTS)
All AMS Penile Prosthesis Recipients - Total ReponsesNumber of Participants With Penile Prosthesis That Were Not Using the Device, Reasons for Non-useLoss of partner8 Participants
All AMS Penile Prosthesis Recipients - Total ReponsesNumber of Participants With Penile Prosthesis That Were Not Using the Device, Reasons for Non-useDevice dissatisfaction17 Participants
All AMS Penile Prosthesis Recipients - Total ReponsesNumber of Participants With Penile Prosthesis That Were Not Using the Device, Reasons for Non-useDevice problem8 Participants
All AMS Penile Prosthesis Recipients - Total ReponsesNumber of Participants With Penile Prosthesis That Were Not Using the Device, Reasons for Non-usePartner disinterest9 Participants
All AMS Penile Prosthesis Recipients - Total ReponsesNumber of Participants With Penile Prosthesis That Were Not Using the Device, Reasons for Non-useOther reason34 Participants
All AMS Penile Prosthesis Recipients - Total ReponsesNumber of Participants With Penile Prosthesis That Were Not Using the Device, Reasons for Non-useHealth decline13 Participants
AMS 700Number of Participants With Penile Prosthesis That Were Not Using the Device, Reasons for Non-usePartner disinterest8 Participants
AMS 700Number of Participants With Penile Prosthesis That Were Not Using the Device, Reasons for Non-useLoss of partner7 Participants
AMS 700Number of Participants With Penile Prosthesis That Were Not Using the Device, Reasons for Non-useDevice problem8 Participants
AMS 700Number of Participants With Penile Prosthesis That Were Not Using the Device, Reasons for Non-useDevice dissatisfaction17 Participants
AMS 700Number of Participants With Penile Prosthesis That Were Not Using the Device, Reasons for Non-useHealth decline13 Participants
AMS 700Number of Participants With Penile Prosthesis That Were Not Using the Device, Reasons for Non-useOther reason34 Participants
AMS AmbicorNumber of Participants With Penile Prosthesis That Were Not Using the Device, Reasons for Non-useDevice dissatisfaction0 Participants
AMS AmbicorNumber of Participants With Penile Prosthesis That Were Not Using the Device, Reasons for Non-usePartner disinterest1 Participants
AMS AmbicorNumber of Participants With Penile Prosthesis That Were Not Using the Device, Reasons for Non-useDevice problem0 Participants
AMS AmbicorNumber of Participants With Penile Prosthesis That Were Not Using the Device, Reasons for Non-useOther reason0 Participants
AMS AmbicorNumber of Participants With Penile Prosthesis That Were Not Using the Device, Reasons for Non-useHealth decline0 Participants
AMS AmbicorNumber of Participants With Penile Prosthesis That Were Not Using the Device, Reasons for Non-useLoss of partner1 Participants
SpectraNumber of Participants With Penile Prosthesis That Were Not Using the Device, Reasons for Non-useLoss of partner0 Participants
SpectraNumber of Participants With Penile Prosthesis That Were Not Using the Device, Reasons for Non-useHealth decline0 Participants
SpectraNumber of Participants With Penile Prosthesis That Were Not Using the Device, Reasons for Non-usePartner disinterest0 Participants
SpectraNumber of Participants With Penile Prosthesis That Were Not Using the Device, Reasons for Non-useDevice dissatisfaction0 Participants
SpectraNumber of Participants With Penile Prosthesis That Were Not Using the Device, Reasons for Non-useDevice problem0 Participants
SpectraNumber of Participants With Penile Prosthesis That Were Not Using the Device, Reasons for Non-useOther reason0 Participants
Primary

Number of Participants With Penile Prosthesis Using the Device But Not as Often as Desired

Number of penile prosthesis subjects using the device but indicated that they were not using as often as desired (effectiveness objective 1) measured using a non-validated, standard question, evaluated overall and by penile prosthesis.

Time frame: 1 year, post implantation

Population: Subjects who received an AMS penile prosthesis and completed 1 year follow-up visit.

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
All AMS Penile Prosthesis Recipients - Total ReponsesNumber of Participants With Penile Prosthesis Using the Device But Not as Often as Desired109 Participants
AMS 700Number of Participants With Penile Prosthesis Using the Device But Not as Often as Desired96 Participants
AMS AmbicorNumber of Participants With Penile Prosthesis Using the Device But Not as Often as Desired9 Participants
SpectraNumber of Participants With Penile Prosthesis Using the Device But Not as Often as Desired4 Participants
Primary

Number of Times Per Month Participants With Penile Prosthesis Are Using the Device.

Penile prosthesis use at 1 year measured in number of times per month (effectiveness objective 1) measured using a non-validated, standard question, evaluated overall and by penile prosthesis.

Time frame: 1 year, post implantation

Population: Subjects who received an AMS penile prosthesis and completed 1 year follow-up visit who hand answered that they were using the device and responded to how many times per month they were using it.

ArmMeasureValue (MEAN)Dispersion
All AMS Penile Prosthesis Recipients - Total ReponsesNumber of Times Per Month Participants With Penile Prosthesis Are Using the Device.6.3 Number of times per monthStandard Deviation 5.5
AMS 700Number of Times Per Month Participants With Penile Prosthesis Are Using the Device.6.3 Number of times per monthStandard Deviation 5.6
AMS AmbicorNumber of Times Per Month Participants With Penile Prosthesis Are Using the Device.5.4 Number of times per monthStandard Deviation 3.3
SpectraNumber of Times Per Month Participants With Penile Prosthesis Are Using the Device.5.2 Number of times per monthStandard Deviation 4.3
Other Pre-specified

American Urology Association - Symptom Index Over Five Years

The AUA-SI contains seven symptoms questions which include feeling of incomplete bladder emptying, frequency, intermittency, urgency, weak stream, straining and nocturia, each referring to during the last month, and each involving assignment of a score from 0 to 5 for a total score of maximum 35 points from non-missing items. The lower score means a better quality of life.

Time frame: Baseline through 5 years

Population: Number of subjects analyzed reduced over time due to attrition. Also, follow-up after 1 year was optional.

ArmMeasureGroupValue (MEAN)Dispersion
All AMS Penile Prosthesis Recipients - Total ReponsesAmerican Urology Association - Symptom Index Over Five YearsBaseline9.0 score on a scaleStandard Deviation 6.9
All AMS Penile Prosthesis Recipients - Total ReponsesAmerican Urology Association - Symptom Index Over Five Years1 year7.9 score on a scaleStandard Deviation 6.6
All AMS Penile Prosthesis Recipients - Total ReponsesAmerican Urology Association - Symptom Index Over Five Years2 year8.8 score on a scaleStandard Deviation 7
All AMS Penile Prosthesis Recipients - Total ReponsesAmerican Urology Association - Symptom Index Over Five Years3 year8.2 score on a scaleStandard Deviation 6.5
All AMS Penile Prosthesis Recipients - Total ReponsesAmerican Urology Association - Symptom Index Over Five Years4 year8.1 score on a scaleStandard Deviation 6.3
All AMS Penile Prosthesis Recipients - Total ReponsesAmerican Urology Association - Symptom Index Over Five Years5 year8.1 score on a scaleStandard Deviation 5.7
Other Pre-specified

Erection Hardness Scale Over Five Years

The Erection Hardness Scale (EHS), an easy-to-use, four-point scale for erectile dysfunction, provides a reliable measure of erection hardness and an indicator of other health and wellbeing outcomes, according to new data reported at the European Association of Urology. EHS rates the hardness of erection on a scale of zero to four, with four being the maximal score. A higher score indicates a harder penis while a lower score indicates greater dysfunction.

Time frame: Baseline through 5 years

Population: Number of subjects analyzed reduced over time due to attrition. Also, follow-up after 1 year was optional.

ArmMeasureGroupValue (MEAN)Dispersion
All AMS Penile Prosthesis Recipients - Total ReponsesErection Hardness Scale Over Five YearsBaseline1.0 score on a scaleStandard Deviation 1.1
All AMS Penile Prosthesis Recipients - Total ReponsesErection Hardness Scale Over Five Years1 year3.4 score on a scaleStandard Deviation 1
All AMS Penile Prosthesis Recipients - Total ReponsesErection Hardness Scale Over Five Years3 year3.5 score on a scaleStandard Deviation 0.9
All AMS Penile Prosthesis Recipients - Total ReponsesErection Hardness Scale Over Five Years4 year3.5 score on a scaleStandard Deviation 1
All AMS Penile Prosthesis Recipients - Total ReponsesErection Hardness Scale Over Five Years5 year3.5 score on a scaleStandard Deviation 0.9
All AMS Penile Prosthesis Recipients - Total ReponsesErection Hardness Scale Over Five Years2 year3.5 score on a scaleStandard Deviation 1
Other Pre-specified

Subject Reported 5-question International Index of Erectile Function (IIEF-5) Total Score, Baseline Through Five Years

Penile prosthesis International Index of Erectile Function (IIEF-5) score (effectiveness objective 2) measured using a validated, multi-dimensional, self-administered questionnaire. Overall responses are reported. A higher score demonstrates an improvement in erectile function while a lower score indicates a loss of erectile function. The 5-question International Index of Erectile Function (IIEF-5) Questionnaire is a validated, multi-dimensional, self-administered investigation that has been found useful in the clinical assessment of erectile dysfunction and treatment outcomes in clinical trials. A score of 0 to 5 is awarded to each of the 5 questions that examine the 4 main domains of male sexual function: erectile function, orgasmic function, sexual desire, and intercourse satisfaction. The subscales are summed to calculated the total score. The minimum total score for this questionnaire is 0 with a maximum of 30.

Time frame: Baseline through 5 years

Population: Number of subjects analyzed reduced over time due to attrition. Also, follow-up after 1 year was optional.

ArmMeasureGroupValue (MEAN)Dispersion
All AMS Penile Prosthesis Recipients - Total ReponsesSubject Reported 5-question International Index of Erectile Function (IIEF-5) Total Score, Baseline Through Five Years3 year21.2 score on a scaleStandard Deviation 6.1
All AMS Penile Prosthesis Recipients - Total ReponsesSubject Reported 5-question International Index of Erectile Function (IIEF-5) Total Score, Baseline Through Five Years4 year20.6 score on a scaleStandard Deviation 6.8
All AMS Penile Prosthesis Recipients - Total ReponsesSubject Reported 5-question International Index of Erectile Function (IIEF-5) Total Score, Baseline Through Five YearsBaseline6.4 score on a scaleStandard Deviation 5.2
All AMS Penile Prosthesis Recipients - Total ReponsesSubject Reported 5-question International Index of Erectile Function (IIEF-5) Total Score, Baseline Through Five Years1 year20.6 score on a scaleStandard Deviation 6.4
All AMS Penile Prosthesis Recipients - Total ReponsesSubject Reported 5-question International Index of Erectile Function (IIEF-5) Total Score, Baseline Through Five Years2 year20.4 score on a scaleStandard Deviation 6.6
All AMS Penile Prosthesis Recipients - Total ReponsesSubject Reported 5-question International Index of Erectile Function (IIEF-5) Total Score, Baseline Through Five Years5 year21.2 score on a scaleStandard Deviation 6.2
Other Pre-specified

UCLA Prostate Cancer Index Over Five Years

The University of California Los Angeles-Prostate Cancer Index -UCLA-PCI is a validated, twenty question questionnaire to asses impact of treatment for early stage prostate cancer on quality of life. The UCLA-PCI is analyzed in six sections, Sexual Function and Sexual Bother, Urinary Function and Urinary Bother, and Bowel Function and Bowel Bother. This is to measure not just the impact on function but also the quality of life impact. The UCLA PCI domain is scored on a scale of 0-100 points with higher values representing better outcomes.

Time frame: Baseline through 5 years

Population: Number of subjects analyzed reduced over time due to attrition. Also, follow-up after 1 year was optional.

ArmMeasureGroupValue (MEAN)Dispersion
All AMS Penile Prosthesis Recipients - Total ReponsesUCLA Prostate Cancer Index Over Five Years3 year71.7 score on a scaleStandard Deviation 20.8
All AMS Penile Prosthesis Recipients - Total ReponsesUCLA Prostate Cancer Index Over Five YearsBaseline21.5 score on a scaleStandard Deviation 16.9
All AMS Penile Prosthesis Recipients - Total ReponsesUCLA Prostate Cancer Index Over Five Years1 year70.9 score on a scaleStandard Deviation 20.9
All AMS Penile Prosthesis Recipients - Total ReponsesUCLA Prostate Cancer Index Over Five Years5 year71.2 score on a scaleStandard Deviation 21.3
All AMS Penile Prosthesis Recipients - Total ReponsesUCLA Prostate Cancer Index Over Five Years2 year70.0 score on a scaleStandard Deviation 21.6
All AMS Penile Prosthesis Recipients - Total ReponsesUCLA Prostate Cancer Index Over Five Years4 year70.3 score on a scaleStandard Deviation 22.2
AMS 700UCLA Prostate Cancer Index Over Five Years4 year86.0 score on a scaleStandard Deviation 19.6
AMS 700UCLA Prostate Cancer Index Over Five Years5 year85.9 score on a scaleStandard Deviation 21.5
AMS 700UCLA Prostate Cancer Index Over Five Years2 year83.4 score on a scaleStandard Deviation 20.8
AMS 700UCLA Prostate Cancer Index Over Five YearsBaseline79.9 score on a scaleStandard Deviation 24.3
AMS 700UCLA Prostate Cancer Index Over Five Years1 year82.6 score on a scaleStandard Deviation 20.9
AMS 700UCLA Prostate Cancer Index Over Five Years3 year83.8 score on a scaleStandard Deviation 21.2
AMS AmbicorUCLA Prostate Cancer Index Over Five Years2 year87.8 score on a scaleStandard Deviation 15.9
AMS AmbicorUCLA Prostate Cancer Index Over Five Years4 year87.8 score on a scaleStandard Deviation 17.3
AMS AmbicorUCLA Prostate Cancer Index Over Five Years5 year86.7 score on a scaleStandard Deviation 19.3
AMS AmbicorUCLA Prostate Cancer Index Over Five Years3 year87.5 score on a scaleStandard Deviation 17.1
AMS AmbicorUCLA Prostate Cancer Index Over Five Years1 year88.4 score on a scaleStandard Deviation 14.3
AMS AmbicorUCLA Prostate Cancer Index Over Five YearsBaseline85.0 score on a scaleStandard Deviation 15.5
SpectraUCLA Prostate Cancer Index Over Five Years3 year78.8 score on a scaleStandard Deviation 32.2
SpectraUCLA Prostate Cancer Index Over Five YearsBaseline10.8 score on a scaleStandard Deviation 22.8
SpectraUCLA Prostate Cancer Index Over Five Years1 year77.3 score on a scaleStandard Deviation 32.7
SpectraUCLA Prostate Cancer Index Over Five Years4 year80.7 score on a scaleStandard Deviation 31.9
SpectraUCLA Prostate Cancer Index Over Five Years5 year83.1 score on a scaleStandard Deviation 29.4
SpectraUCLA Prostate Cancer Index Over Five Years2 year77.9 score on a scaleStandard Deviation 33.2
UCLA-PCI Urinary BotherUCLA Prostate Cancer Index Over Five Years5 year80.5 score on a scaleStandard Deviation 28.3
UCLA-PCI Urinary BotherUCLA Prostate Cancer Index Over Five Years2 year80.5 score on a scaleStandard Deviation 27.3
UCLA-PCI Urinary BotherUCLA Prostate Cancer Index Over Five Years1 year81.1 score on a scaleStandard Deviation 26.6
UCLA-PCI Urinary BotherUCLA Prostate Cancer Index Over Five Years3 year79.0 score on a scaleStandard Deviation 28.3
UCLA-PCI Urinary BotherUCLA Prostate Cancer Index Over Five Years4 year79.9 score on a scaleStandard Deviation 27.3
UCLA-PCI Urinary BotherUCLA Prostate Cancer Index Over Five YearsBaseline76.7 score on a scaleStandard Deviation 31.6
UCLA-PCI Bowel BotherUCLA Prostate Cancer Index Over Five Years4 year86.6 score on a scaleStandard Deviation 24.3
UCLA-PCI Bowel BotherUCLA Prostate Cancer Index Over Five Years1 year87.3 score on a scaleStandard Deviation 22.3
UCLA-PCI Bowel BotherUCLA Prostate Cancer Index Over Five Years5 year84.8 score on a scaleStandard Deviation 26
UCLA-PCI Bowel BotherUCLA Prostate Cancer Index Over Five Years3 year86.8 score on a scaleStandard Deviation 23.7
UCLA-PCI Bowel BotherUCLA Prostate Cancer Index Over Five Years2 year86.5 score on a scaleStandard Deviation 23.5
UCLA-PCI Bowel BotherUCLA Prostate Cancer Index Over Five YearsBaseline85.5 score on a scaleStandard Deviation 24.1

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026